Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
Beatrice Maranini, Giovanni Ciancìo, Rosario Cultrera, Marcello Govoni
Abstract
Since the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) pandemic outbreak, vaccines gained a growing role. Possible vaccine-related side effects range from minor local events to more prominent systemic manifestations up to anaphylactic reactions. A heterogeneous spectrum of cutaneous reactions has been reported, ranging from local injection site reactions to urticarial and morbilliform eruptions, pernio/chilblains and zoster flares. Here, we describe a case of varicella zoster virus reactivation following mRNA coronavirus 2019 vaccine and discuss the available literature upon the topic published so far.
Topics & Concepts
MedicineAnkylosing spondylitisOutbreakDermatologyVirologyCoronavirusCoronavirus disease 2019 (COVID-19)ImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PathologyDiseaseInfectious disease (medical specialty)Herpesvirus Infections and TreatmentsDermatological and COVID-19 studiesBartonella species infections research